Earnings News
Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.
GE HealthCare Cuts 2026 Profit View on Rising Costs, Stock Plunges
GE HealthCare cut its 2026 profit forecast as rising chip, oil, and freight costs, along with tariffs, squeezed margins. Shares fell nearly 13%.
Cognizant Shares Slide as Weak Guidance, Cost-Cutting Plan Overshadow $600M AI Deal
Cognizant shares dropped after second-quarter revenue guidance fell short of analyst forecasts, overshadowing a $600 million deal for AI firm Astreya and a new cost-cutting program.
NXP Surges on Auto Chip Revival and Strong Forecast
NXP shares jumped up to 25% after the company forecast Q2 revenue and profit above Wall Street estimates, signaling a rebound in automotive and industrial chip demand.
Google Parent Alphabet Faces AI Spending Scrutiny Ahead of Q1 Earnings
Alphabet reports Q1 earnings Wednesday. Analysts expect $107B revenue, with focus on AI spending, Google Cloud growth, and Gemini's impact.
Enphase Energy Shares Tumble as Q1 Earnings Reveal Persistent Solar Demand Weakness
Enphase Energy shares fell 7.3% after Q1 revenue dropped to $282.9 million and a GAAP loss of $7.4 million, as U.S. solar demand continued to decline. Adjusted earnings beat estimates, but investors remain skeptical.
Western Digital Shares Climb on Seagate's Strong AI Storage Outlook
Western Digital (WDC) shares surged 9.3% after Seagate's (STX) strong quarterly outlook boosted the storage sector, highlighting AI-driven demand for HDDs.
Generac Surges on Raised 2026 Outlook as Data Center Demand Drives Growth
Generac raised its 2026 outlook after Q1 net sales rose 12%, driven by data center demand. Shares jumped 11% as adjusted EPS of $1.80 topped estimates.
Lemonade Surges on Q1 Revenue Beat, Lifts 2026 Guidance
Lemonade shares jumped 5.6% premarket after Q1 revenue surged 71% to $258M, beating estimates. The company raised its 2026 revenue outlook to $1.203B and narrowed its net loss.
Biogen Lowers 2026 Profit View Despite Q1 Beat; Leqembi Sales Soar 74%
Biogen lowered its 2026 adjusted earnings outlook to $14.25-$15.25 per share after Q1 results topped estimates. Leqembi sales jumped 74% to $168M globally.
Visa Shares Surge on Strong Earnings, Raised Forecast, and $20B Buyback
Visa shares jumped 5% premarket Wednesday after the company beat profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Payments volume rose 9% and cross-border volume 12%, signaling resilient consumer spending.
Regeneron Q1 Results Top Estimates, Eylea Challenges Loom
Regeneron reported strong Q1 results with revenue up 19% and earnings above estimates, but Eylea sales declined and an FDA delay on a new syringe manufacturer weighs on shares.
Humana Shares Slide Despite Q1 Earnings Beat as Medicare Advantage Challenges Persist
Humana beat Q1 profit estimates but shares fell over 6% premarket as it kept its 2026 outlook unchanged and cut GAAP guidance, citing Medicare Star Ratings headwinds.